Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra-Reference-Cited by-同舟云学术

Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra

Published:2014-03 Issue: Volume:261 Page:79-88
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Konieczny Jolanta,Czarnecka Anna,Lenda Tomasz,Kamińska Kinga,Lorenc-Koci Elżbieta

Funder

Polish MNiSW

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference58 articles.

1. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system;Ehringer;Klin Wochenschr,1960

2. Paralysis agitans. I. Pathologische anatomic;Lewy,1912

3. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies;Spillantini;Proc Natl Acad Sci USA,1998

4. The pathogenesis of cell death in Parkinson's disease – 2007;Olanow;Mov Disord,2007

5. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg;Ciechanover;Neuron,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases;Redox Biology;2024-02

2. Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies;Current Neuropharmacology;2023-05

3. The use of the proteasome inhibitor lactacystin for modeling Parkinson’s disease: Early neurophysiological biomarkers and candidates for intranigral and extranigral neuroprotection;Handbook of Animal Models in Neurological Disorders;2023

4. Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease;European Journal of Pharmacology;2021-11

5. Animal models for preclinical Parkinson's research: An update and critical appraisal;Progress in Brain Research;2020